Metabolomic insights into amphetamine-type stimulant misuse: unraveling biochemical pathways and biomarkers [0.03%]
代谢组学对苯丙胺类兴奋剂滥用的见解：解析生物化学途径和生物标志物
Ruzmayuddin Mamat,Baharudin Ibrahim,Rusdi Abd Rashid et al.
Ruzmayuddin Mamat et al.
Amphetamine-type stimulants (ATS), such as methamphetamine, amphetamine, and MDMA, are highly risky substances linked to neurochemical disruptions, metabolic disturbances, and systemic toxicity. Despite substantial research on their neuroto...
President's message [0.03%]
总裁寄语
Darrin Mangiacarne
Darrin Mangiacarne
Breaking the cycle: a systematic review of neurobiological mechanisms and psychotherapeutic innovations in ketamine addiction [0.03%]
打破循环：卡特明成瘾神经生物学机制和心理治疗创新的系统评价
Christopher Lomas
Christopher Lomas
This systematic review synthesizes current evidence on non-prescribed ketamine use, emphasizing its neurobiological impacts and psychotherapeutic interventions. Patterns of misuse demonstrate the complex interplay of neurobiological, socio-...
Spatial analysis of methamphetamine and amphetamine use disorder among Alabama Medicaid recipients in rural and urban areas [0.03%]
农村和城市地区阿拉巴马州医疗补助接受者使用甲基安非他命和安非他命障碍的空间分析
Haelim Jeong,Karen Johnson,Ellen Robertson et al.
Haelim Jeong et al.
Background: The current study uses geographic information system (GIS) methods to better understand structural risks significantly associated with substance misuse and how those risks may be driven by urbanicity versus ru...
Alicia Collette Podwojniak,Kathy Chen,Benjamin Pullinger et al.
Alicia Collette Podwojniak et al.
Oxymetazoline hydrochloride 0.05% is a lipophilic sympathomimetic nasal decongestant spray available over the counter (OTC) and commonly used for allergic and chronic rhinitis. A well-known side effect of these nasal sprays is rebound conge...
Switching to levomethadone improves methadone-induced hyperhidrosis: A case report [0.03%]
换用莱沃美沙朵治疗美沙朵引起的多汗症病例报告
Tiziano Serfilippi,Silvia Piccirillo,Francesca Romagnoli et al.
Tiziano Serfilippi et al.
Methadone maintenance therapy is the cornerstone of treatment for heroin addiction. Hyperhidrosis is a common and often-overlooked side effect of methadone. Different medications, such as antihistamines and anticholinergic drugs, have been ...
Evaluating remyelination compounds for new applications in opioid use disorder management [0.03%]
评估神经重塑化合物在阿片类药物使用障碍管理中的新应用
Gouri Sharma,Quinn Wade,Nicholas M Graziane
Gouri Sharma
Opioid use disorder (OUD) is associated with a reduction in brain white matter, affecting critical areas involved in decision-making, impulse control, and reward processing. The FDA has approved several drugs and natural compounds that enha...
A pilot study of ketamine among individuals with tobacco use disorder: tolerability and initial impact on tobacco use outcomes [0.03%]
氯胺酮治疗烟草使用障碍的试点研究：耐受性和对烟草使用的初始影响
Janice Chuang,Riley Carpenter Lide,Nikhil Kamath et al.
Janice Chuang et al.
Objectives: There is increasing evidence of ketamine's therapeutic potential in reducing substance use in individuals with substance use disorders. However, its effects on tobacco use disorder are unknown. We investigated...
Preliminary examination of orexin receptor antagonism with suvorexant in individuals with Methamphetamine use disorder: a case series study [0.03%]
索維雷克桑抗組胺治療甲基苯丙胺成癮的初步研究：病例系列研究
Heather Webber,Jessica Badawi,Douglas Calvillo et al.
Heather Webber et al.
Background: No FDA-approved medications for methamphetamine (MA) use disorder (MUD) are available. Suvorexant (SUVO), a dual orexin receptor antagonist that is FDA approved for insomnia treatment, reduces MA self-administration and MA-induc...
enCompass: evaluation of a community-based substance use disorder stigma intervention [0.03%]
基于社区的精神活性物质使用障碍污名干预评估项目
Valerie A Earnshaw,Ginnie Sawyer-Morris,Braeden Kelly et al.
Valerie A Earnshaw et al.
Introduction: Stigma within communities is pervasive and a barrier to substance use disorder (SUD) treatment. The current proof-of-concept study evaluated enCompass, a community-based SUD knowledge and stigma intervention...